Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to assess the impact of smoking on cortical GABA levels in males and females. Using magnetic resonance spectroscopy (MRS), we will examine the impact of sex and menstrual cycle phase on brain neurochemistry in healthy smokers and non-smokers. We hypothesize that female, but not male, smokers will have reduced cortical GABA levels compared to their non-smoking, sex-matched counterparts.


Clinical Trial Description

The purpose of this study is to measure and compare gamma-aminobutyric acid (GABA) levels in the occipital cortex of a group of healthy smoking and non-smoking women and men ages 18-50. We will recruit women with regular menstrual cycles so that we can assess premenstrual impact of smoking cessation in that population and compare GABA level concentrations across all groups. Although there are several note-worthy differences between male and females in regard to smoking behavior, ultimately none are as worrisome as the disparity in ability to quit smoking. While multiple explanations for why women are less successful in their abstinence attempts have been proffered, the observation that women are more likely to experience emergence of depressive symptoms during smoking cessation, a known risk factor for relapse, may be the most important contributor to this sex-specific recidivism. Several lines of evidence suggest that nicotine modulation of GABA may play an important role in this interplay between sex, depression, and smoking recidivism. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01227343
Study type Observational
Source University of Pennsylvania
Contact
Status Completed
Phase
Start date March 2010
Completion date November 2017

See also
  Status Clinical Trial Phase
Terminated NCT03576768 - QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt N/A
Completed NCT04124432 - Behavioral Pharmacology of Cannabis and Nicotine Phase 1
Enrolling by invitation NCT04038515 - Impact of Flavors on Nicotine Perception and Self-Administration Via E-cigarettes Phase 2
Completed NCT01223404 - Nicotinic Modulation of the Default Network N/A
Recruiting NCT05864586 - Developing E-liquid Product Standards (Sweet Spot Study) N/A
Completed NCT05317195 - Nicotine Pharmacokinetics and Subjective Effects of Nicotine Pouch 1.0 Compared to Velo® Ice Cool and Zyn® Cool Mint Mini Dry in Healthy Smokers N/A
Withdrawn NCT03010995 - The Acute Cardiovascular Effects of Nicotine in E-cigarettes (ACE) Study Phase 1
Active, not recruiting NCT04189146 - Inner Engineering Yoga Program on Short and Long Term Health Effects (ISHA-Impact): A Longitudinal Study N/A
Completed NCT05487456 - Reduced HPHC Exposure in Cigarette Smokers Switching to P4M3 Gen. 2.0 Compared to Continuing Smoking, or Smoking Abstinence N/A
Completed NCT03102931 - Switching to Low Oxidant Content Cigarettes in Adult Smokers N/A
Completed NCT03134339 - The Effect of Nicotine Delivery Rate on Reinforcement Early Phase 1
Recruiting NCT06346353 - Substance Consumption, Personality, and Cognitive Functioning of Chess Players
Completed NCT05383508 - Nicotine Pharmacokinetics Following Use of the P4M3 Gen 2.0 E-Cigarette Compared to Smoking Cigarettes N/A